Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF

NCT01937130 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

23

Enrollment

INDUSTRY

Sponsor class

Stopped Data needs met

Conditions

Acute on Chronic Hepatic Failure
Acute Liver Failure
Liver Cirrhosis
Acute Alcoholic Hepatitis

Interventions

DRUG: IDN-6556
OTHER: Placebo

Sponsor

Conatus Pharmaceuticals Inc.